EUVIMEDEUVIMED entdecken
Crossref

Nanofibrous Bioabsorbable Functionalized Scaffolds Augment Subcutaneous Islet Engraftment and Function in Mice

Purushothaman Kuppan, Chelsea Castro, Joy Paramor, Kosala D Waduthanthri, Nerea Cuesta-Gomez, Arghyadip Bose, Ivan Ma, Mandy Rosko, Andrew R Pepper iD, Gregory S Korbutt iD

Diabetes · 01.08.2026 · 75 (8) · 1424-1436

DOI: 10.2337/db26-0149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, online erschienen am 04.06.2026. Verfasst von Purushothaman Kuppan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Islets of Langerhans Transplantation, Tissue Scaffolds, Nanofibers, Islets of Langerhans. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Alberta Diabetes Foundation Scholarship, Juvenile Diabetes Research Foundation (JDRF) Career Development Award, Juvenile Diabetes Research Foundation (JDRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The subcutaneous (SQ) space is a promising site for islet transplantation to treat type 1 diabetes. We hypothesize that nanofibrous bioabsorbable functionalized scaffolds (BAFS) implanted in the SQ space will create a highly vascularized niche that will support islet engraftment. Electrospun poly(lactic-co-glycolic acid) (PLGA) and gelatin (G) (PLGA + G) scaffolds functionalized with vascular endothelial growth factor (V) and laminin (L) were wrapped around a nylon catheter and implanted into the SQ space of immunodeficient mice. Experimental groups included PLGA, PLGA + G, PLGA + G + V + L, and the device-less catheter alone. The degree of vascularization in these sites was assessed 4 weeks after implantation, and in a separate cohort of mice, neonatal porcine islets (NPIs) were transplanted subcutaneously into diabetic mice. NPIs transplanted under the kidney capsule served as controls. PLGA + G + V + L recipients showed enhanced vascularization, with a higher number of cells positive for lectin, smooth muscle actin, and CD31 compared with other groups (P < 0.05). Recipients of PLGA + G + V + L scaffolds and NPIs achieved normoglycemia faster (P < 0.05) and exhibited higher serum porcine insulin levels (P < 0.05) compared with all other groups. Our nanofibrous BAFS (PLGA + G + V + L) significantly vascularized the SQ space and supported long-term islet graft survival, suggesting a clinically relevant and tunable alternative site for β-cell replacement therapies. Article Highlights This study highlights how bioabsorbable functionalized scaffolds (BAFS) create a subcutaneous vascularized niche that supports islet graft function. BAFS exhibit sustained release of vascular endothelial growth factor and laminin, which promoted enhanced vascularization in the subcutaneous space. Additionally, these vessels are mature and patent as evidenced by intraluminal cells positive for lectin and smooth muscle actin. BAFS transplanted with neonatal porcine islets achieved normoglycemia faster and exhibited higher serum porcine insulin levels than all other groups. Overall, BAFS transplanted with neonatal porcine islets facilitates long-term islet graft function and corrects diabetes in mice, suggesting a clinically relevant and tunable alternative site for β-cell replacement therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Islets of Langerhans TransplantationTissue ScaffoldsNanofibersIslets of LangerhansDiabetes Mellitus, ExperimentalAnimalsMicePolylactic Acid-Polyglycolic Acid CopolymerLactic AcidGelatinSwinePolyglycolic AcidVascular Endothelial Growth Factor ALamininAbsorbable ImplantsNeovascularization, PhysiologicGraft SurvivalMale

Substanzen

Polylactic Acid-Polyglycolic Acid CopolymerLactic AcidGelatinPolyglycolic AcidVascular Endothelial Growth Factor ALaminin

Autor:innen und Institutionen

  • Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.
  • Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.
  • Department of Chemical and Materials Engineering, University of Alberta, Edmonton, Alberta, Canada.

ORCID-Profile: Andrew R Pepper, Gregory S Korbutt

Förderung

  • Alberta Diabetes Foundation Scholarship
  • Juvenile Diabetes Research Foundation (JDRF) Career Development Award
  • Juvenile Diabetes Research Foundation (JDRF)
  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Kuppan, P., Castro, C., Paramor, J., Waduthanthri, K. D., Cuesta-Gomez, N., Bose, A., Ma, I., Rosko, M., Pepper, A. R., & Korbutt, G. S. (2026). Nanofibrous Bioabsorbable Functionalized Scaffolds Augment Subcutaneous Islet Engraftment and Function in Mice. Diabetes, 75(8), 1424-1436. https://doi.org/10.2337/db26-0149

Vancouver

Kuppan P, Castro C, Paramor J, Waduthanthri KD, Cuesta-Gomez N, Bose A, et al. Nanofibrous Bioabsorbable Functionalized Scaffolds Augment Subcutaneous Islet Engraftment and Function in Mice. Diabetes. 2026;75(8):1424-1436. doi:10.2337/db26-0149

BibTeX
@article{Kuppan2026,
  author = {Kuppan, Purushothaman and Castro, Chelsea and Paramor, Joy and Waduthanthri, Kosala D and Cuesta-Gomez, Nerea and Bose, Arghyadip and Ma, Ivan and Rosko, Mandy and Pepper, Andrew R and Korbutt, Gregory S},
  title = {Nanofibrous Bioabsorbable Functionalized Scaffolds Augment Subcutaneous Islet Engraftment and Function in Mice},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {8},
  pages = {1424--1436},
  doi = {10.2337/db26-0149}
}
Kostenlos starten →